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Objective: Hypoxic exposure can be used as a therapeutic tool by inducing
various cardiovascular, neuromuscular, and metabolic adaptations. Hypoxic conditioning
strategies have been evaluated in patients with chronic diseases using either sustained
(SH) or intermittent (IH) hypoxic sessions. Whether hypoxic conditioning via SH or IH may
induce different physiological responses remains to be elucidated.
Methods: Fourteen healthy active subjects (7 females, age 25 ± 8 years, body mass
index 21.5 ± 2.5 kg·m−2) performed two interventions in a single blind, randomized
cross-over design, starting with either 3 x SH (48 h apart), or 3 x IH (48 h apart), separated
by a 2 week washout period. SH sessions consisted of breathing a gas mixture with
reduced inspiratory oxygen fraction (FiO2), continuously adjusted to reach arterial oxygen
saturations (SpO2) of 70–80% for 1 h. IH sessions consisted of 5min with reduced
FiO2 (SpO2 = 70–80%), followed by 3-min normoxia, repeated seven times. During
the first (S1) and third (S3) sessions of each hypoxic intervention, cardiorespiratory
parameters, and muscle and pre-frontal cortex oxygenation (near infrared spectroscopy)
were assessed continuously.
Results : Minute ventilation increased significantly during IH sessions (+2 1± 2 L·min− )
while heart rate increased during both SH (+11 ± 4 bpm) and IH (+13 ± 5 bpm)
sessions. Arterial blood pressure increased during all hypoxic sessions, although baseline
normoxic systolic blood pressure was reduced from S1 to S3 in IH only (−8± 11 mmHg).
Muscle oxygenation decreased significantly during S3 but not S1, for both hypoxic
interventions (S3: SH −6 ± 5%, IH −3 ± 4%); pre-frontal oxygenation decreased in
S1 and S3, and to a greater extent in SH vs. IH (−13 ± 3% vs. −6 ± 6%). Heart
rate variability indices indicated a significantly larger increase in sympathetic activity in
SH vs. IH (lower SDNN, PNN50, and RMSSD values in SH). From S1 to S3, further
reduction in heart rate variability was observed in SH (SDNN, PNN50, and RMSSD
reduction) while heart rate variability increased in IH (SDNN and RMSSD increase).
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Conclusions: These results showed significant differences in heart rate variability, blood
pressure, and tissue oxygenation changes during short-term SH vs. IH conditioning
interventions. Heart rate variability may provide useful information about the early
adaptations induced by such intervention.
Keywords: hypoxic conditioning, sustained hypoxia, intermittent hypoxia, blood pressure, heart rate variability,
tissue oxygenation
INTRODUCTION
Although chronic hypoxia is known to be an aggravating factor in
several cardiovascular and respiratory diseases, hypoxic exposure
may also be of significant benefits to one’s cardiorespiratory status
as demonstrated in animal models (e.g., Béguin et al., 2005)
and as reviewed recently by our group (Verges et al., 2015) and
others (Almendros et al., 2014; Navarrete-Opazo and Mitchell,
2014; Mateika et al., 2015). Hypoxic exposure as a potential
therapeutic aid is a promising rehabilitation method for many
clinical populations, including hypertensive (Serebrovskaya et al.,
2008) and overweight (Kayser and Verges, 2013) patients.
Unlike in chronic respiratory failure where hypoxia is most
often associated with hypoventilation and hypercapnia, the
combination of hypoxia, hyperventilation (and slight resultant
hypocapnia) can be used to exploit certain physiological benefits
of hypoxic exposure e.g., decreased blood pressure observed in
animal models and hypertensive patients after repeated hypoxic
exposures (Serebrovskaya et al., 2008). Indeed, exposure to
either normobaric or hypobaric hypoxia has historically been
implemented to improve athletic performance through various
physiological mechanisms, including increased hemoglobinmass
and enhanced muscle capilarization and metabolic capacities
(reviewed in Millet et al., 2010). From this perspective, and
using methods previously employed in sport medicine, repeated
hypoxic exposures, i.e., hypoxic conditioning, may be seen
as a new preventive, and therapeutic strategy, especially for
deconditioned individuals.
Unfortunately, current research in the field of hypoxic
conditioning does not provide the optimal hypoxic exposure
required to obtain protective or therapeutic effects. It is now
recognized that the consequences of hypoxic exposure depend
on a dose–response relationship ranging from normoxia to
deleterious severe hypoxia [intermittent inspiratory oxygen
fraction (FiO2) < 0.08–0.10 and arterial oxygen saturation
(SpO2) <70%, with short cycles <2min], with intermediate
doses (moderate hypoxia, FiO2 > 0.10 or SpO2 ≥ 70–80%) and
patterns (intermittent hypoxia with >5-min cycles or sustained
hypoxia) of hypoxia that can have positive cardiovascular and
metabolic effects (Navarrete-Opazo and Mitchell, 2014; Verges
et al., 2015). Previous studies on hypoxic conditioning in healthy
subjects and patients used two main types of hypoxic exposure,
with repetitive sessions of either intermittent [IH, e.g., 3–7min
hypoxia and 3–5min normoxia, repeated 3–10 times (Bernardi
et al., 2001a; Burtscher et al., 2004; Lyamina et al., 2011; Zhang
et al., 2014)] or sustained [SH, e.g., 1 h under sustained hypoxia
(Rodríguez et al., 1999; Katayama et al., 2001, 2009; Lusina
et al., 2006)] hypoxia. Whether these two types of hypoxic
conditioning may induce different adaptations needs to be
elucidated in order to establish optimal hypoxic conditioning
strategies.
The possible deleterious side-effects of hypoxia
[cardiovascular and metabolic dysfunctions as observed in
sleep apnoea syndrome for instance: increased blood pressure,
impaired glucose, and lipid metabolism (Lévy et al., 2011)] have
to be considered when applying hypoxic conditioning strategy,
especially to higher-risk, clinical populations. The hypoxic dose
and pattern used for hypoxic conditioning should probably be
adapted depending on patient characteristics and individual
responses. The determination of the optimal hypoxic dose
should occur during the beginning of the hypoxic conditioning
program (i.e., over the first sessions) in order to avoid either
insufficient (and therefore no treatment effect) or too severe (and
its potential deleterious side-effects) hypoxic stimuli. Monitoring
the efficiency and safety of hypoxic conditioning strategies
requires to identify physiological biomarkers reflecting the
early responses (during the first session and over the following
sessions) to hypoxic conditioning.
Acute hypoxia induces within the first minutes and hours
of exposure typical cardiorespiratory and autonomic nervous
system responses including hyperventilation, tachycardia, and
increased sympathetic activity. These mechanisms have been
especially studied in the context of acute and chronic altitude
exposure, i.e., prolonged sustained hypoxia (several hours and
days staying at altitude, Mazzeo, 2008). While some of these
mechanisms may be helpful in monitoring the effect of hypoxic
conditioning strategies, few data are available in the literature
regarding the main physiological responses during and after
repetitive SH or IH conditioning sessions. Changes in blood
pressure and autonomic nervous system are potential relevant
markers of the physiological changes induced by repetitive
hypoxic exposure. Severe intermittent hypoxia as encountered
in sleep apnoea alters baroreflex activity and increases blood
pressure (Lévy et al., 2011) while hypoxic conditioning strategy
may improve baroreflex sensitivity (Haider et al., 2009) and
reduce blood pressure (Serebrovskaya et al., 2008). Changes in
heart rate variability (a useful marker of the autonomic nervous
system activity, Malik, 1996) induced during and after hypoxic
conditioning sessions remain to be elucidated. For example,
it is known that after 12 h of sustained hypoxia (4000m), a
pronounced (dampened) effect on heart rate variability is evident,
even 1 h after returning to normoxic ambient air (Guger et al.,
2008), while after a brief hypoxic exposure of 15min (FiO2 =
0.11), the hypoxia-induced reduction in heart rate variability
disappears almost immediately (Roche et al., 2002). Hence,
in order to provide potential physiological biomarkers for the
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implementation of hypoxic conditioning strategies, the effects of
repetitive SH or IH exposure over several days need to be clarified
especially on important cardiovascular mechanisms such as the
autonomic nervous system.
Another issue to consider when applying hypoxic
conditioning strategies is the determination of tissue-
specific responses to hypoxic exposure which are generally
characterized based on the magnitude of arterial blood
deoxygenation. Important differences in oxygenation levels
between tissues have been shown when FiO2 is reduced both
in animal models (Almendros et al., 2011; Reinke et al.,
2011) and in healthy subjects (Rupp et al., 2011, 2016). Rupp
et al. (2016) demonstrated that healthy subjects exposed
to intermittent hypoxemia for 45min showed significant
cyclical prefrontal cortex deoxygenation while the biceps
brachialis muscle remained normoxic. Hence, changes in
tissue (especially muscle and brain) oxygenation as measured
non-invasively by near-infrared spectroscopy (NIRS) need
to be characterized in order to better determine the organ-
specific hypoxic stress applied during hypoxic conditioning
sessions.
Therefore, the purpose of this study was to assess the
acute and short-term cardiorespiratory and tissue oxygenation
effects of two hypoxic conditioning strategies (i.e., sustained
vs. intermittent hypoxic exposures as previously used in the
literature) in order to determine the most efficient strategy
and to identify physiological biomarkers able to provide
early assessment of each hypoxic conditioning program, with
emphasis on distinguishing protective vs. deleterious responses.
We hypothesized that IH conditioning would induce larger
cardiorespiratory (i.e., improved blood pressure and heart
rate variability) benefits due to repetitive deoxygenation-
reoxygenation cycles compared to SH conditioning.
MATERIALS AND METHODS
Subjects
Fourteen (7 females) active, healthy volunteers (age: 25 ± 8
years, body mass: 72 ± 11 kg, height: 179 ± 7 cm, body mass
index 21.5 ± 2.5 kg·m−2) were included in the present study
after routine medical assessment consisting of a short clinical
examination, a 12-lead electrocardiogram and a respiratory
function test. All subjects were non-smokers and had no history
of cardiorespiratory or neuromuscular disease. They lived at
sea level (Grenoble, 212m) and were not exposed to altitude
>1000m over the past 3 months. Subjects were engaged 1–3
times a week in low- to moderate-intensity endurance activities
such as walking, jogging, or cycling. They were instructed to
keep their diet, hydration status, and physical activity routine
identical throughout the study. Subjects refrained from physical
exercise the days prior to the tests, abstained from drinking
caffeinated beverages on test days, and had their last meal at
least 2 h prior to the tests. The study was approved by the local
ethics committee (CPP Sud-Est V) and performed according to
the Declaration of Helsinki. Subjects were fully informed of the
procedure and risks involved and gave their written consent prior
to all assessments.
Experimental Design
In this prospective, randomized, cross-over, controlled, single-
blind study performed in Grenoble (altitude: 210m), all
participants performed first a full familiarization trial in
normoxia including sitting and breathing quietly through
a facemask, with continuous electrocardiogram and blood
pressure measurements. Then, they were randomized (using
block randomization) into either the sustained hypoxia (SH) or
intermittent hypoxia (IH) condition. After performing the first
hypoxic condition (three ∼1-h sessions separated by 48 h), all
subjects completed the second hypoxic condition (three ∼1-h
sessions separated by 48 h) after a minimum washout period of
15 days. Cardiorespiratory and NIRS signals were continuously
recorded on session 1 (S1), and session 3 (S3) of each hypoxic
condition (described below). On session 2, only SpO2 and FiO2
were recorded. This study focused on physiological responses
over three sessions of each hypoxic conditioning strategy since
this represents a reasonable time frame (1 week) to assess the
early effects of this intervention (Rodway et al., 2007) and to
adapt, if required, the hypoxic dose.
In all testing sessions subjects seated in a semi-supine position,
in a quiet environment, at rest but without sleeping. They were
blinded for the gas mixture composition they were inhaling.
Subjects were told that this study aimed to compare the effect of
two different types of hypoxic exposure, without further details.
The hypoxic stimulus was obtained by having subjects breathe via
a facemask a nitrogen-enriched gas mixture provided by a gas-
mixing device (Altitrainer R©, SMTEC S.A., Nyon Switzerland).
FiO2 was individually adjusted to reach the targeted SpO2 of 70–
80% in both hypoxic conditioning interventions (see Figure 1).
Sustained Hypoxia (SH) Sessions
SH sessions started with an initial phase of 5min breathing
normoxic, ambient air for baseline data collection. Then, the
hypoxic phase began with a progressive decrease of FiO2 from
0.21 to 0.10 over 10min. Afterwards, FiO2 was automatically
adjusted to reach 70–80% SpO2. This target SpO2 level was
sustained until 55 min of hypoxic exposure. There was a final
normoxic recovery phase where participants breathed ambient
air for an additional 10min, for a total testing duration of 70min.
Intermittent Hypoxia (IH) Sessions
IH sessions consisted of a 5min baseline breathing normoxic,
ambient air, followed by seven cycles of 5-min hypoxia (breathing
a gas mixture with reduced FiO2 to reach the target SpO2of 70–
80%) and 3-min normoxic breathing. The initial 5-min hypoxia
was performed with a FiO2 of 0.10 for all subjects, and FiO2 was
individually adjusted for the subsequent 5-min hypoxic phases
in order to reach the target SpO2. After the seven hypoxia–
normoxia cycles, 7min of normoxic recovery were performed for
a total session duration of 68min.
Cardiorespiratory Measurements
Ventilation and gas exchanges were monitored continuously
breath-by-breath using the MetaMax 3B (Cortex Biophysik
GmbH, Leipzig, Germany). Gas analyzers and volume
transducers were calibrated prior to each test with a 3-L syringe
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FIGURE 1 | Inspiratory oxygen fraction (FiO2, A,B) and arterial oxygen saturation (SpO2, C,D) during the first (S1) and the third (S3) sustained or intermittent
hypoxia sessions. Data points are means ± SD. Gray areas indicate hypoxic phases. *Significantly different from normoxic baseline in both S1 and S3 (p < 0.05,
two-way ANOVA main effect of time).
and references gases, respectively, according to manufacturer’s
instructions. Blood pressure was measured on the dominant arm
twice at each time point with a digital pressure monitor system
(A&D Medical, Kitamoto-Shi, Japan). ECG was continuously
recorded using a 2-lead ECG at a sampling rate of 1000Hz
(Holter AFT 1000, Holter supplies, Paris, France).
NIRS Measurements
Oxy[HbO2]-, deoxy[HHb]-, and total[HbTot]-hemoglobin
concentration changes and tissue oxygenation index (TSI) were
estimated continuously throughout testing sessions over multiple
sites using a two-wavelength (780 and 850 nm) multichannel,
continuous wave NIRS system (Oxymon MkIII, Artinis Medical
Systems, Netherlands). Muscle hemodynamics were assessed at
the middle of right biceps brachialis using a 4-cm interoptode
distance. Left pre-frontal cortex hemodynamics were assessed
between Fp1 and F3 locations according to the international
10–20 EEG system with 3.5-cm inter-optode distance. The
probe holders were secured to the skin with double-sided
tape and maintained with Velcro bands. Data were recorded
continuously at 10Hz and filtered with a 2-s width moving
Gaussian smoothing algorithm before analysis.
Data Analysis
ECG data was transferred to the QuickReader software (Holter
supplies) and R–R intervals were analyzed by means of the
Kubios HRV Analysis Software 2.2 (Tarvainen et al., 2002, 2014).
Heart rate variability parameters were recorded and calculated
in accordance with the task force of the European society
of cardiology and the North American society of pacing and
electrophysiology (Malik, 1996). Data were visually inspected
to remove artifacts and heart rate variability parameters were
calculated over 5-min periods. The following parameters were
used to analyze the heart rate variability within the time domain:
standard deviation of R–R interval (SDNN), percentage of
successive R–R that varied by 50ms or more (PNN50) and the
root-mean-square difference of successive normal R–R intervals
(RMSSD). In the frequency domain, the following parameters
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were calculated using a Fast Fourier Transform: low frequency
(LF; 0.04–0.15Hz), high frequency (HF; 0.15–0.40Hz), and
LF/HF ratio.
During SH sessions, minute ventilation (VE), gas exchanges,
heart rate, SpO2, and NIRS parameters were averaged over the
last 30 s of the baseline normoxic phase, of each 5-min periods
in hypoxia and of the normoxic recovery phase. During IH
sessions, the same parameters were averaged over the last 30 s
of the baseline normoxic phase, of each 5-min hypoxic, and 3-
min normoxic periods, and of the normoxic recovery phase.
Arterial blood pressure was calculated as the average of two
measurements at each of these time points. Heart rate variability
parameters were calculated over the 5-min baseline normoxic
phase, every 5min during the hypoxic phase of SH sessions and
during every 5-min hypoxic phases of IH sessions, and over the
last 5min of the normoxic recovery phase.
Statistical Analysis
All statistical procedures were completed on Statistica version 10
(Statsoft, Tulsa, OK). Normality of distribution and homogeneity
of variances of the main variables were confirmed using a
Shapiro-Wilk normality test and the Levene’s test, respectively.
For each hypoxic condition (SH and IH), in order to assess
changes over time within the sessions and changes from S1 to
S3, a two-way ANOVA (time × session) with repeated measures
was performed for each dependent variable (see statistical results
provided in figures). In order to assess differences between
hypoxic conditions (SH vs. IH), a three-way ANOVA (time ×
session × condition) with repeated measures was performed for
each dependent variable, using four time points only [baseline
normoxia, min 25 (mid-session) and 60 (end-session) in SH and
min 26 (mid-session) and 58 (end-session) in IH, and normoxic
recovery). These four time points were selected in order to
compare SH and IH under similar hypoxemic conditions, i.e., at
mid and end hypoxic phase, when SpO2 remained at the same
70–80% target value for at least 5 min in both SH and IH (see
statistical results provided in tables). Post-hoc Tukey’s tests were
applied to determine a difference between two mean values if the
ANOVA revealed a significant main effect or interaction effect.
For all statistical analyses, a two-tailed alpha level of 0.05 was
used as the cut-off for significance. All data are presented as mean
values± SD within text and tables.
RESULTS
Subjects reported no significant discomfort and no adverse effect
was observed during all SH and IH sessions.
Inspiratory Oxygen Fraction and Arterial
Oxygenation
Changes in FiO2 and SpO2 during the hypoxic conditioning
sessions are presented in Figure 1 and Table 1. FiO2 was
significantly reduced from baseline normoxic values throughout
SH sessions (two-way ANOVA main effect of time F = 807.5,
p < 0.001) and during the hypoxic phases of IH sessions (two-
way ANOVA main effect of time F = 4762.0, p < 0.001). FiO2
reduction magnitude was similar between S1 and S3 in both
conditions (SH two-way ANOVA, main effect of session F =
1.4, p = 0.262; IH two-way ANOVA main effect of session
F = 1.0, p = 0.340) and was significantly larger at mid- and
end-session in IH vs. SH (three-way ANOVA condition × time
interaction F = 30.2, p < 0.001; Table 1). SpO2 was reduced
from baseline normoxic values throughout SH sessions (two-way
ANOVAmain effect of time F = 171.5, p< 0.001) and during the
hypoxic phases of IH sessions (two-way ANOVA main effect of
time F= 213.7, p< 0.001). SpO2 reduction (SH 77.5± 1.7 and IH
78.2 ± 3.2%, on average during the hypoxic phases) was similar
between S1 and S3 in both conditions (SH two-way ANOVA
main effect of session F = 0.5, p = 0.482; IH two-way ANOVA
main effect of session F = 1.7, p = 0.211) and was significantly
larger at the end of the session in SH vs. IH (three-way ANOVA
condition× time interaction F = 3.1, p= 0.040; Table 1).
Cardiorespiratory Responses
Changes in VE and PetCO2 during the hypoxic conditioning
sessions are presented in Figure 2 and Table 1. A significant
increase in VE from baseline normoxic values was observed
during the hypoxic phases of IH sessions both in S1 and S3 (two-
way ANOVA main effect of time F = 6.1, p < 0.001) but not
during SH sessions (two-way ANOVA main effect of time F =
1.6, p = 0.108). PetCO2 decreased significantly from baseline
normoxic values during SH sessions both in S1 and S3 (two-
way ANOVA main effect of time F = 9.0, p < 0.001) and during
the hypoxic phases of IH sessions both in S1 and S3 (two-way
ANOVAmain effect of time F = 10.2, p< 0.001). VE and PetCO2
changes did not differ between SH and IH at mid- and end-
session (VE three-way ANOVA condition × time interaction F
= 0.6, p = 0.617; PetCO2 three-way ANOVA condition × time
interaction F = 0.6, p= 0.612; Table 1).
Changes in heart rate and arterial blood pressure during
the hypoxic conditioning sessions are presented in Figure 3
and Table 1. A significant increase in heart rate from baseline
normoxic values was observed throughout SH sessions (two-way
ANOVA main effect of time F = 30.0, p < 0.001) and during the
hypoxic phases of IH sessions (two-way ANOVA main effect of
time F = 57.5, p < 0.001) both in S1 and S3. Heart rate increase
was similar in SH and IH (three-way ANOVA main condition
effect F = 1.4, p = 0.251; Table 1). Systolic blood pressure (SBP)
increased significantly from baseline normoxic values during SH
both in S1 and S3 (two-way ANOVA main effect of time F =
21.0, p < 0.001) while it increased during IH in S3 only (two-
way ANOVA session × time interaction F = 2.1, p = 0.013).
Baseline normoxic SBP was significantly reduced at S3 compared
to S1 in IH (p= 0.009). Diastolic blood pressure (DBP) increased
significantly from baseline normoxic values during SH and IH
both in S1 and S3 (SH two-way ANOVA main effect of time F =
5.5, p < 0.001; IH two-way ANOVA main effect of time F = 6.5,
p < 0.001). Changes in SBP and DBP did not differ between SH
and IH conditions (Table 1).
Heart Rate Variability
Changes in heart rate variability parameters during the hypoxic
conditioning sessions are presented in Figures 4, 5 and Table 2.
SDNNdecreased significantly in SH during S3 (two-way ANOVA
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FIGURE 2 | Minute ventilation (VE, A,B) and end-tidal CO2 partial pressure (PetCO2, C,D) during the first (S1) and the third (S3) sustained or intermittent hypoxia
sessions. Data points are means ± SD. Gray areas indicate hypoxic phases. *Significantly different from normoxic baseline in both S1 and S3 (p < 0.05, two-way
ANOVA main effect of time).
condition × time interaction F = 2.9, p = 0.001) and increased
significantly in IH during both S1 and S3 (two-way ANOVAmain
effect of time F = 3.2, p = 0.003). SDNN in IH was significantly
larger during S3 compared to S1 (two-way ANOVAmain effect of
session F = 4.9, p = 0.045). SDNN was significantly lower in SH
compared to IH (three-way ANOVAmain effect of condition F=
23.4, p< 0.001; three-way ANOVA condition× time interaction
F = 5.8, p = 0.002; Table 2). PNN50 decreased during both S1
and S3 in SH (two-way ANOVA main effect of time F = 10.1, p
< 0.001) and IH (two-way ANOVA main effect of time F = 5.9,
p < 0.001) sessions. PNN50 in SH decreased to a greater extent
during S3 compared to S1 (two-way ANOVA condition × time
interaction F = 5.8, p= 0.002). PNN50 was significantly lower in
SH compared to IH (three-way ANOVAmain effect of condition
F = 8.7, p = 0.011; Table 2). RMSSD decreased during S3 in SH
(two-way ANOVA session× time interaction F = 3.3, p< 0.001)
and during both S1 and S3 in IH (two-way ANOVA main effect
of time F = 4.6, p < 0.001) sessions. RMSSD in SH decreased
to a greater extent during S3 compared to S1 (two-way ANOVA
session × time interaction F = 3.3, p < 0.001) while in IH it was
larger during S3 compared to S1 (two-way ANOVA main effect
of session F = 4.2, p = 0.046). RMSSD was significantly lower in
SH compared to IH (three-way ANOVAmain effect of condition
F = 8.9, p= 0.010; Table 2).
LF did not change during both S1 and S3 in SH (two-way
ANOVAmain effect of time F = 1.8, p= 0.054) and IH (two-way
ANOVA main effect of time F = 1.4, p = 0.207). HF decreased
significantly during both S1 and S3 in SH (two-way ANOVA
main effect of time F = 8.4, p< 0.001) and IH (two-way ANOVA
main effect of time F = 6.6, p< 0.001) sessions. LF/HF increased
significantly during both S1 and S3 in SH (two-way ANOVA
main effect of time F = 4.6, p < 0.001) but not in IH (two-way
ANOVA main effect of time F = 0.5, p = 0.868). LF/HF did
not differ significantly between SH and IH (three-way ANOVA
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FIGURE 3 | Heart rate (HR, A,B) and systolic and diastolic blood pressure (C,D) during the first (S1) and the third (S3) sustained or intermittent hypoxia sessions.
Data points are means ± SD. Gray areas indicate hypoxic phases. *Significantly different from normoxic baseline in both S1 and S3 (p < 0.05, two-way ANOVA main
effect of time); +Significantly different from normoxic baseline in S3 only (p < 0.05, two-way ANOVA session × time interaction); $Significant difference between S1
and S3 (p < 0.05, two-way ANOVA session × time interaction).
main effect of condition F = 0.2, p = 0.658; three-way ANOVA
condition× time interaction F = 1.5, p= 0.231; Table 2).
Tissue Oxygenation
Changes in muscle NIRS parameters during the hypoxic
conditioning sessions are presented in Figures 6, 7 and Table 3.
Muscle TSI decreased significantly in S3 but not in S1 during
both SH (two-way ANOVA session × time interaction F = 3.1,
p = 0.001) and IH (two-way ANOVA session × time interaction
F = 2.3, p = 0.006) sessions. Muscle TSI reduction was similar
between SH and IH conditions (three-way ANOVA condition
× time interaction F = 2.2, p = 0.109; Table 3). Muscle HHb
(SH two-way ANOVA session × time interaction F = 3.1, p =
0.001; IH two-way ANOVA session × time interaction F = 2.3,
p = 0.007) but not HbO2 (SH two-way ANOVA session × time
interaction F = 1.7, p = 0.077; IH two-way ANOVA session ×
time interaction F = 1.1, p = 0.395) nor HbTot (SH two-way
ANOVA session × time interaction F = 1.8, p = 0.052; IH two-
way ANOVA session × time interaction F = 1.2, p = 0.311)
showed larger changes in S3 compared to S1 in both SH and
IH conditions. HbO2 reduction (three-way ANOVA condition×
time interaction F= 3.1, p= 0.037) andHHb increase (three-way
ANOVA condition × time interaction F = 3.8, p = 0.017) were
larger during SH compared to IH conditions (Table 3).
Changes in pre-frontal cortex NIRS parameters during the
hypoxic conditioning sessions are presented in Figures 6, 8 and
Table 3. Pre-frontal cortex TSI decreased significantly during
both S1 and S3 in SH (two-way ANOVA main effect of time
F = 75.4, p < 0.001) and IH (two-way ANOVA main effect
of time F = 9.8, p < 0.001) sessions. Pre-frontal cortex HbO2
significantly decreased (SH two-way ANOVAmain effect of time
F = 36.7, p < 0.001; IH two-way ANOVA main effect of time
Frontiers in Physiology | www.frontiersin.org 8 January 2017 | Volume 7 | Article 675
Chacaroun et al. Hypoxic Conditioning Strategies
FIGURE 4 | Heart rate variability indices within the time domain [standard deviation of R–R interval (SDNN), (A,B); percentage of successive R–R that
varied by 50ms or more (PNN50), (C,D); root-mean-square difference of successive normal R–R intervals (RMSSD), (E,F)] during the first (S1) and the third (S3)
sustained or intermittent hypoxia sessions. Data points are means ± SD. Gray areas indicate hypoxic phases. *Significantly different from normoxic baseline in both
S1 and S3 (p < 0.05, two-way ANOVA main effect of time); +Significantly different from normoxic baseline in S3 only (p < 0.05, two-way ANOVA session × time
interaction); #Significantly different from normoxic baseline in S1 only (p < 0.05, two-way ANOVA session × time interaction); $Significant difference between S1 and
S3 (p < 0.05, two-way ANOVA main effect of session or session × time interaction).
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FIGURE 5 | Heart rate variability indices within the frequency domain [low frequency in normalized units (LF), (A,B); high frequency in normalized units
(HF), (C,D); LF/HF ratio, (E,F)] during the first (S1) and the third (S3) sustained or intermittent hypoxia sessions. Data points are means ± SD. Gray areas indicate
hypoxic phases. *Significantly different from normoxic baseline in both S1 and S3 (p < 0.05, two-way ANOVA main effect of time).
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FIGURE 6 | Tissue oxygenation index (TSI) for the muscle (A,B) and the prefrontal cortex (C,D) during the first (S1) and the third (S3) sustained or intermittent
hypoxia sessions. Data points are means ± SD. Gray areas indicate hypoxic phases. *Significantly different from normoxic baseline in both S1 and S3 (p < 0.05,
two-way ANOVA main effect of time); +Significantly different from normoxic baseline in S3 only (p < 0.05, two-way ANOVA session × time interaction).
F = 12.7, p < 0.001) whereas HHb significantly increased (SH
two-way ANOVA main effect of time F = 98.7, p < 0.001; IH
two-way ANOVA main effect of time F = 16.4, p < 0.001)
during both S1 and S3 in SH and IH. Pre-frontal cortex HbTot
did not change over time both in SH (two-way ANOVA main
effect of time F = 0.9, p = 0.519) and IH (two-way ANOVA
main effect of time F = 1.7, p = 0.056). Pre-frontal cortex
TSI (three-way ANOVA condition × time interaction F = 15.4,
p < 0.001) and HbO2 (three-way ANOVA condition × time
interaction F = 10.2, p < 0.001) reduction as well as HHb
increase (three-way ANOVA condition × time interaction F
= 13.2, p < 0.001) were larger during SH compared to IH
conditions (Table 3).
Changes in pre-frontal cortex TSI, HbO2, and HHb during SH
and IH conditions were larger than changes at the muscle level
(all p< 0.05).
DISCUSSION
The present study aimed to assess the acute and short-term
(3 sessions) cardiorespiratory and tissue oxygenation responses
to two hypoxic conditioning strategies, i.e., SH and IH,
in order to determine their respective effects and potential
physiological biomarkers able to detect early adaptations. During
SH and IH sessions (acute effects), hyperventilation, tachycardia,
increased blood pressure, and reduced heart rate variability were
observed. SH sessions were associated with larger reduction in
heart rate variability and greater muscle and prefrontal cortex
deoxygenation compared to IH sessions. From S1 to S3 (short-
term adaptations), IH reduced normoxic SBP and increased
heart rate variability, SH sessions induced further reduction in
heart rate variability, while both SH and IH sessions induced
larger muscle deoxygenation. Hence, these results emphasize
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FIGURE 7 | Muscle oxy- ([HbO2], A,B), deoxy- ([HHb], C,D), and total- ([HbTot], E,F) hemoglobin concentration changes during the first (S1) and the third (S3)
sustained or intermittent hypoxia sessions. Data points are means ± SD. Gray areas indicate hypoxic phases. *Significantly different from normoxic baseline in both
S1 and S3 (p < 0.05, two-way ANOVA main effect of time); $Significant difference between S1 and S3 (p < 0.05, two-way ANOVA session × time interaction).
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FIGURE 8 | Pre-frontal cortex oxy- ([HbO2], A,B), deoxy- ([HHb], C,D), and total- ([HbTot], E,F) hemoglobin concentration changes during the first (S1) and the
third (S3) sustained or intermittent hypoxia sessions. Data points are means ± SD. Gray areas indicate hypoxic phases. *Significantly different from normoxic baseline
in both S1 and S3 (p < 0.05, two-way ANOVA main effect of time).
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differences between SH and IH conditioning strategies regarding
cardiovascular and tissue oxygenation responses and suggest
some early adaptations after three hypoxic conditioning sessions
only.
Acute Cardiorespiratory Responses
Acute hypoxic exposure is known to induce an increase
in ventilation within the first minutes of exposure due to
stimulation of peripheral chemoreceptors Mazzeo (2008). In
the present study, a significant increase in VE was observed
during the 5-min hypoxic phases of IH sessions but not
during SH sessions (Figure 1). One potential reason for this
difference between SH and IH is the progressive reduction in
FiO2 over the first 10 min of hypoxic exposure during SH
sessions while during IH subjects were switched instantaneously
from normoxia to a gas mixture with a FiO2 of 0.10,
possibly inducing greater chemoreceptor stimulation. Significant
reductions in PetCO2 during SH and IH sessions indicate
however that subjects hyperventilated during both types of
hypoxic exposure (Figure 2). The hypoxic hyperventilatory
response was nevertheless relatively modest since VE increased
by <2 L·min−1 and PetCO2 decreased by <3mmHg on
average whatever the hypoxic condition, which is consistent with
previous observations during SH and IH conditioning sessions
[∼50-min IH with 5–6min FiO2 = 0.10–4min FiO2 = 0.21
(Zhang et al., 2014); 1-h SH or IH at SpO2 = 80–90% (Rodway
et al., 2007)]. This modest increase in ventilation probably
contributed to the absence of significant discomfort reported by
all subjects during both SH and IH sessions.
Acute hypoxic exposure is also known to induce tachycardia
as observed during both SH and IH sessions (Figure 3), due to
a combination of factors including aortic bodies stimulation and
modulation of the autonomous nervous system Mazzeo (2008).
Changes in arterial blood pressure during acute hypoxic exposure
result from the opposite effect of hypoxia-induced peripheral
vasodilation (Crawford et al., 2006) and sympathetic activation
(Halliwill et al., 2003). Previous studies reported inconsistent
changes in arterial blood pressure during acute SH or IH
exposure with no change [∼50-min IH with 5–6min FiO2 =
0.10–4min FiO2 = 0.21 (Zhang et al., 2014)] or slight increase [1-
h SH at SpO2 = 80% (Lusina et al., 2006), 1-h SH or IH at SpO2 =
80–90% (Rodway et al., 2007), 1-h IH with 5–7min normocapnic
rebreathing–5–7min FiO2 = 0.21 (Bernardi et al., 2001b)]. In
the present study both SH and IH induced a significant increase
in blood pressure (Figure 3) which may be of larger magnitude
compared to some previous studies due to the relatively low
target SpO2 (70–80%).
Heart rate variability is generally increased during acute
hypoxic exposure which is thought to reflect sympathetic
activation and parasympathetic withdrawal (Roche et al., 2002).
In the present study, heart rate variability decreased during SH
and IH sessions (from baseline normoxic exposure) suggesting a
shift in the sympathovagal balance due to sympathetic activation
as suggested by the increased LF/HF ratio in SH (Figure 5)
and vagal withdrawal as suggested by reduced PNN50 and
RMSSD in both SH and IH (Figure 4; Malik, 1996). Because
changes in ventilation were modest in the present study
and more pronounced in the hypoxic condition associated
with smaller changes in heart rate variability (i.e., IH), it is
likely that changes in heart rate variability reflected alterations
in the sympathovagal balance rather than respiratory sinus
node modulation (Hirsch and Bishop, 1981). Interestingly,
the reduction in heart rate variability was larger during SH
compared to IH as shown by lower SDNN, PNN50, and
RMSSD values during SH compared to IH sessions (Table 2).
A greater effect of SH might be explained by the larger dose
of hypoxia characterizing SH sessions compared to IH sessions
due to the sustained hypoxic pattern of exposure (without
reoxygenation phases as in IH) and the slightly lower SpO2
(2–3% lower at mid- and end-session) in SH compared to IH
sessions (Table 1). The importance of the total hypoxic dose
has also been suggested by Tamisier et al. (2005) who observed
a larger increase in muscle sympathetic nerve activity after 2
h of SH (SpO2 ∼ 85%) vs. 2 h of IH (∼2-min cycles with
minimum SpO2 ∼ 85%). The more severe reduction of heart
rate variability during SH compared to IH observed in the
present (Table 2) and previous studies is however in contrast
to previous observations suggesting greater cardiorespiratory
alterations due to intermittent vs. sustained hypoxia in rats (8-
h/day IH with 15 s FiO2 = 0.05–5min FiO2 = 0.21; 4-h/day
SH at ∼6500m), possibly due to oxidative stress associated
with repetitive deoxygenation–reoxygenation cycles (Peng and
Prabhakar, 2004). In the later study, the cycle duration and
hypoxia severity were nevertheless shorter and more severe,
respectively, (and therefore potentially more harmful) whichmay
explain these contrasting results when comparing SH and IH
exposures.
Under similar hypoxemic levels (i.e., similar target SpO2
in SH and IH), the present study demonstrates that (i) SH
induces larger reductions in muscle (larger HbO2 and HHb
but not TSI changes) and even more pre-frontal cortex (larger
HbO2, HHb, and TSI changes) oxygenation compared to IH
sessions (Table 3) and (ii) larger reductions in pre-frontal cortex
than muscle oxygenation are induced during both SH and IH
sessions (Figure 6). Of note, these changes in tissue oxygenation
occurred together with unchanged HbTot both at the pre-
frontal cortex and muscle levels (Figures 7, 8), suggesting no
significant change in local blood flow. Although the slightly
greater reduction in SpO2 during SH compared to IH (∼2%
difference, Table 1) may have contributed to the greater tissue
deoxygenation during SH sessions, it is unlikely to explain the
large difference in tissue oxygenation between both hypoxic
conditions (Table 3). Since we have previously shown that both
muscle and cerebral deoxygenations display slower kinetics than
arterial deoxygenation when FiO2 is reduced (Rupp et al.,
2013), it can be suggested that 5-min hypoxic phases during
IH sessions did not allow maximal muscle and pre-frontal
cortex deoxygenation compared to prolonged and sustained
arterial oxygenation reduction characterizing SH sessions (where
maximal deoxygenation required up to 30 min of hypoxic
exposure, Figure 6). Whether the larger cerebral deoxygenation
induced by SH compared to IH sessions contributed to some
differences in cardiorespiratory responses observed between the
two types of hypoxic exposure in the present study (e.g., the
Frontiers in Physiology | www.frontiersin.org 16 January 2017 | Volume 7 | Article 675
Chacaroun et al. Hypoxic Conditioning Strategies
greater reduction in heart rate variability in SH compared to IH)
remains to be elucidated.
The larger reduction in pre-frontal cortex oxygenation
compared to muscle oxygenation during both SH and IH
sessions (Figure 6) is in accordance with the greater cerebral
oxygenation sensitivity to reduction in arterial oxygenation
previously reported by our group under both sustained [FiO2 =
0.12 (Rupp et al., 2013)] and intermittent [100 s FiO2 = 0.12–20 s
FiO2 = 1.0 (Rupp et al., 2016)] hypoxia, possibly due to greater
basal metabolic activity and the inability to recruit additional
capillaries at the cerebral compared to the muscle level. In
order to induce significant deoxygenation and therefore potential
adaptations within the muscle, coupling hypoxic exposure and
physical exercise may be an attractive hypoxic conditioning
strategy to consider (Millet et al., 2016).
Short-Term Cardiorespiratory Adaptations
While chronic hypoxic exposure such as at high altitude
is known to increase the hypoxic ventilatory response [e.g.,
5 days at 4350m (Rupp et al., 2014)], repeated bouts of
intermittent hypoxia have also been shown to increase hypoxic
chemosensitivity [7 days, 1–3-h/day SH with FiO2 = 0.12
(Katayama et al., 2009); 10 days, 1-h/day SH at SpO2 =
80% (Lusina et al., 2006); 14 days, 1-h/day IH with 5–7 min
normocapnic rebreathing—5–7min FiO2 = 0.21 (Bernardi et al.,
2001b); 10 days, 1-h/day IH with 5min FiO2 = 0.12–5min
FiO2 = 0.21 (Foster et al., 2005)]. In the present study, three
sessions of hypoxic conditioning did not change the ventilatory
response during SH or IH (Figure 2) while previous studies
reported increased hypoxic ventilatory responses after at least
seven hypoxic sessions (Bernardi et al., 2001b; Foster et al.,
2005; Lusina et al., 2006; Katayama et al., 2009). Changes in
hypoxic ventilatory response may require a larger amount of
hypoxic conditioning sessions than performed in the present
study. Hypoxic heart rate response has been reported to be
reduced [∼50-min IH with 5–6min FiO2 = 0.10–4min FiO2
= 0.21, (Zhang et al., 2014)] or unchanged [7 days, 1-h/day SH at
4500m (Katayama et al., 2001); 10 days, 1-h/day IH with 5min
FiO2 = 0.12–5min FiO2 = 0.21 (Foster et al., 2005)] by repeated
exposure to intermittent hypoxia. In the present study, the SH- or
IH-induced increases in HR were similar at S1 and S3 (Figure 3),
indicating no change in heart rate hypoxic response after three
hypoxic conditioning sessions.
While SH induced similar increase in blood pressure during
S1 and S3, a significant increase in SBP was observed in IH
during S3 only, due to a reduction in baseline normoxic value
compared to S1 (Figure 3). This ∼8mmHg SBP reduction
is of significance in healthy young subjects and in terms of
cardiovascular prevention, and may represent a true effect of
IH conditioning on vascular tone. Shatilo et al. (2008) reported
similar reduction in blood pressure in healthy older individuals
(61 ± 2 years) following 10 days of IH conditioning (40min/day
IH with 5-min FiO2 = 0.12–5-min FiO2 = 0.21). Several
studies also suggested that in patients with hypertension, hypoxic
conditioning programs can significantly reduce blood pressure
[see for a review (Serebrovskaya et al., 2008)]. Lyamina et al.
(2011) for instance reported in patients with stage 1 hypertension
a significant decrease in blood pressure (>20 and >15 mmHg
systolic and DBP reduction, respectively) after 20 days of IH
conditioning (30–60min/day IH with 3min FiO2 = 0.10–
3min FiO2 = 0.21). Hence, the present study suggests that
even in healthy young subjects with normal blood pressure
and no cardiovascular risk factor, early improvements in blood
pressure can occur after only three IH conditioning sessions.
Improvements in blood pressure after hypoxic conditioning may
be due to changes in the autonomic function (with augmented
parasympathetic tone), increased endothelial NO production and
enhanced vasoactive factors such as vascular endothelial growth
factor (Serebrovskaya et al., 2008). The results of the present
study suggesting that IH conditioning may be more efficient
in reducing blood pressure compared to SH conditioning are
in accordance with the study by Rodway et al. (2007) showing
some specific effects of IH (3 days, 1-h IH with 10min SpO2
= 80–90%—10min FiO2 = 0.21) compared to SH (3 days, 1-
h SH with SpO2 = 80–90%) in young healthy subjects, i.e.,
an increase in nitric oxide synthases expression in circulating
lymphocytes negatively correlated with blood pressure after three
IH conditioning sessions only.
Interestingly, from S1 to S3, opposite changes in heart rate
variability were observed in SH compared to IH conditions
(Table 2). Greater reduction in overall heart rate variability (as
suggested by lower SDNN) and larger vagal withdrawal (as
suggested by lower PNN50 and RMSSD) were observed in SH
after three sessions. Conversely, IH was associated with larger
overall heart rate variability (as suggested by larger SDNN) and
greater parasympathetic activity (as suggested by larger RMSSD)
at S3 compared to S1. Previous studies have reported that similar
IH protocols than the present study but over longer durations
also increased heart rate variability [14 days, ∼50-min IH with
5–6min FiO2 = 0.10–4min FiO2 = 0.21 (Zhang et al., 2014); 16
days, 1-h/day IH with 5min FiO2 = 0.16–0.10–5min FiO2 =
0.21 (Lizamore et al., 2016)], while Lusina et al. (2006) reported
that 10 daily 1-h SH exposures with SpO2= 80% in healthy young
subjects increased muscle sympathetic nerve activity both during
and after hypoxic exposure. These previous results together
with the present data suggest important differences regarding
changes in heart rate variability induced by repetitive SH vs. IH
exposures. Improved heart rate variability and possibly increased
parasympathetic activity following three sessions of IH in the
present study (Figure 4) may underlie the reduction in normoxic
SBP observed at S3 in this condition. Although the significance of
these early and opposite changes in heart rate variability indices
observed in SH and IH needs to be further investigated, the
present data suggest that measurements of heart rate variability
may provide useful physiological biomarkers to monitor the
effects of hypoxic conditioning strategies.
From S1 to S3, and according to the study design, similar
reductions in arterial oxygenation were induced in both SH and
IH conditions (Figure 1). The similar reductions in pre-frontal
cortex oxygenation from S1 to S3 (Figure 8) suggest that, as
opposed to the effect of several days of sustained hypoxia [5 days
at 4350m (Rupp et al., 2014)] or intermittent hypoxic exposure
[10 days, 1-h/day IH with 5min FiO2 = 0.12–5min FiO2 = 0.21
(Foster et al., 2005)], no early changes in hypoxic cerebrovascular
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responses were induced. In contrast to the pre-frontal cortex,
muscle deoxygenation was larger in S3 compared to S1 both in
SH and IH (Figure 7). The reduction in muscle TSI, an index of
tissue oxygenation, reached significance at S3 only both during
SH and IH (Figure 6). These results suggest that while during
the first session of hypoxic conditioning the muscle is minimally
exposed to hypoxia despite substantial reduction in arterial
oxygenation level, the repetition of hypoxic sessions accentuates
muscle deoxygenation for identical reduction in SpO2. This may
suggest that the potential effects of hypoxic conditioning on the
muscle (if any) may require several sessions to be induced. The
reasons for this reduction in muscle oxygenation triggered after
several hypoxic conditioning sessions remain to be determined
but larger muscle sympathetic nerve activity as observed by
Lusina et al. (2006) after 10 daily 1-h SH exposures with
SpO2 = 80% may contribute to reduced muscle perfusion and
oxygenation, at least in SH condition.
Limitations
Although the present study provides several important insights
into the acute and short-term responses to SH and IH
conditioning strategies, several other potential adaptations
remain to be evaluated such as hematological and metabolic
changes or exercise cardiorespiratory responses. The effects of
SH and IH conditioning protocols also need to be compared
over more prolonged duration (e.g., several weeks) as usually
performed to induce health benefits. The present study focused
however on acute differences and early adaptations to hypoxic
conditioning strategies in order to provide potential physiological
biomarkers able to monitor the benefits and potential deleterious
consequences of these hypoxic conditioning interventions.
Females were included in the present study without taking
account of potential effects of menstrual cycles on hypoxic
responses. Although recent results indicate that the menstrual
cycle may not affect hypoxic ventilatory responses for instance
(Macnutt et al., 2012), future studies on hypoxic conditioning
should clarify the effect of menstrual cycle. Finally, the present
data applies to healthy young subjects and further studies are
needed to evaluate the acute and short-term responses to similar
hypoxic conditioning strategies in older individuals and in
patients at risk of or with cardiovascular or cerebrovascular
abnormalities.
Practical Considerations
The present study aimed to provide practical information
useful to design hypoxic conditioning interventions for healthy
subjects. These results also give a rational to further develop
and investigate hypoxic conditioning interventions for patients,
especially regarding the type of hypoxic exposure (SH vs.
IH) and the potential physiological biomarkers that could
be used during the first sessions in order to detect early
adaptations. During SH sessions, larger homeostasis disruption
seemed to occur compared to IH sessions, at least when
considering the larger reduction in heart rate variability and
greater tissue deoxygenation in SH compared to IH sessions
(Tables 2, 3). Although this larger physiological stress in SH
was well tolerated in the present population, it seemed to be
associated with less favorable adaptations over three sessions
compared to IH, at least regarding the improved heart rate
variability and normoxic SBP observed from S1 to S3 in IH
only. The lack of muscle deoxygenation during S1 and the
relatively modest muscle deoxygenation level (compared to
the pre-frontal cortex especially) at S3 suggest that both SH
and IH at rest may not provide sufficient muscle homeostasis
disruption in order to induce significant muscular adaptations
(e.g., metabolic). Combining hypoxic exposure and muscular
exercise (i.e., hypoxic exercise training) might be an attractive
strategy especially to induce muscle adaptations. At last, the
present study suggests that monitoring heart rate variability
during and after hypoxic conditioning sessions may provide a
useful physiological biomarker able to detect early adaptations
and to indicate whether the hypoxic dose is adequate for a
given individual. These practical considerations should help
to implement hypoxic conditioning strategies to more fragile
populations such as older individuals or patients with chronic
diseases for instance.
CONCLUSIONS
The present results showed significant differences in heart
rate variability and tissue (especially cerebral) oxygenation
changes during acute SH vs. IH exposures in healthy young
subjects. In addition, after three hypoxic conditioning sessions,
IH only induced significant reduction in normoxic SBP while
SH and IH induced opposite effects (i.e., a reduction and an
increase, respectively) on heart rate variability. Hence this study
indicates that the pattern of hypoxic exposure (i.e., sustained vs.
intermittent) during hypoxic conditioning intervention should
be carefully selected and suggests that heart rate variability may
provide useful information about the early adaptations induced
by such intervention.
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